//
Parsemus Foundation is a private corporation based in SAN FRANCISCO, CA. The foundation received its IRS ruling in 2017. The principal officer is % Matthew E Woodhead. It holds total assets of $2.9M. Annual income is reported at $467K. Womens HealthThe foundations main effort in 2023 was preparing for the launch of a new program on womens hormonal health. The scope of the project was expanded from menopause health to womens hormonal health across the lifespan. The new project is called Hormonally.Under the leadership of a new program director, research on the scope of the program was completed and the new mission set.The research, design, and content-creation for the full Hormonally.org website was completed. The launch of the website is expected in January, 2024.To gather data and make contacts, the director attended womens health conferences,including The Swell Menopause Conference, the European Congress on Menopause, the Womens Health Conference, and the European Menopause and Andropause Meeting.Fee-for-service funding concepts were evaluated. A dedicated webpage on menopause was created for the Parsemus Foundation website, including associated infographics and posts. According to available records, Parsemus Foundation has made 20 grants totaling $454K, with a median grant of $5K. Annual giving has decreased from $371K in 2020 to $39K in 2023. Individual grants have ranged from $100 to $257K, with an average award of $23K. The foundation has supported 13 unique organizations. The foundation primarily supports organizations in Minnesota, Louisiana, Oregon, which account for 25% of all grants. Grantmaking reaches organizations across 8 states. Contributions to this foundation are tax-deductible.
Womens HealthThe foundations main effort in 2023 was preparing for the launch of a new program on womens hormonal health. The scope of the project was expanded from menopause health to womens hormonal health across the lifespan. The new project is called Hormonally.Under the leadership of a new program director, research on the scope of the program was completed and the new mission set.The research, design, and content-creation for the full Hormonally.org website was completed. The launch of the website is expected in January, 2024.To gather data and make contacts, the director attended womens health conferences,including The Swell Menopause Conference, the European Congress on Menopause, the Womens Health Conference, and the European Menopause and Andropause Meeting.Fee-for-service funding concepts were evaluated. A dedicated webpage on menopause was created for the Parsemus Foundation website, including associated infographics and posts.
Expenses: $380K
Animal welfare and alternative sterilization methodsParsemus Foundation has supported research and advocacy on alternatives to traditional sterilization methods, providing extensive information on our website for pet owners. The foundation also offers information on enhanced animal welfare standards, treatment of benign prostatic hyperplasia, and hormone restoration therapy in dogs.The foundation serves as a primary resource for information on hormone-sparing sterilization options for dogs, including management of a directory of veterinarians who offer alternative sterilization procedures for pets.We created a new explainer video about the use of pulsed electromagnetic therapy for benign prostatic hyperplasia in dogs.A new research study on testosterone hormone restoration was launched in 2023 with expected results in 2024.In the past year, the Parsemus Foundation has provided general support for Amici Cannis and the Alliance for Contraception in Cats and Dogs.We distributed educationa
Expenses: $182K
Infectious disease research and advocacyParsemus Foundation continued to support the dissemination of the COVID-OUT clinical trial results, which reported the benefits of metformin to treat COVID-19 symptoms and Long COVID. The Parsemus Foundation supported media management for the announcement of the results of the COVID-OUT clinical trial for Long COVID. Press release and social media were completed in coordination with the University of Minnesotas communications department.We created new infographics and website/social media materials related to the findings about metformin for COVID-19 and Long COVID.A publication award was provided to Dr. Carolyn Bramante for the COVID-OUT clinical trial results publication.The foundation supported the Optimmunize Conference, which brought together researchers working on the non-specific effects of vaccines.A new webpage on vaccine non-specific effects was launched.
Womens HealthThe foundations main effort in 2023 was preparing for the launch of a new program on womens hormonal health. The scope of the project was expanded from menopause health to womens hormonal health across the lifespan. The new project is called Hormonally.Under the leadership of a new program director, research on the scope of the program was completed and the new mission set.The research, design, and content-creation for the full Hormonally.org website was completed. The launch of the website is expected in January, 2024.To gather data and make contacts, the director attended womens health conferences,including The Swell Menopause Conference, the European Congress on Menopause, the Womens Health Conference, and the European Menopause and Andropause Meeting.Fee-for-service funding concepts were evaluated. A dedicated webpage on menopause was created for the Parsemus Foundation website, including associated infographics and posts. Based on available records, the foundation has funded 20 grants. Its grantmaking reaches organizations primarily in MN, LA, OR.
Parsemus Foundation has distributed a total of $454K across 20 grants. The median grant size is $5K, with an average of $23K. Individual grants have ranged from $100 to $257K.
Parsemus Foundation typically selects its grantees rather than accepting unsolicited proposals.
Parsemus Foundation is headquartered in SAN FRANCISCO, CA. While based in CA, the foundation distributes grants to organizations across 8 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Linda Brent Phd Mba | Exec. Dir. | $156K | $0 | $156K |
| Elaine A Lissner | Trustee | $0 | $0 | $0 |
Total Giving
$795K
Total Assets
$3.6M
Fair Market Value
$3.6M
Net Worth
$1.8M
Grants Paid
$39K
Contributions
$218K
Net Investment Income
$36K
Distribution Amount
$0
Total: $38K
Total Grants
20
Total Giving
$454K
Average Grant
$23K
Median Grant
$5K
Unique Recipients
13
Most Common Grant
$3K
of 2023 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| University Of SaskatchewanLithiam Orotate Study. | Saskatoon | $15K | 2023 |
| Amici Cannis UsaGeneral Support | Fort Collins, CO | $10K | 2023 |
| University Of Southern DenmarkGeneral Support | Odense | $6K | 2023 |
| Alliance For Contraception Cats DogContribution to ACC&D | Ann Arbor, MI | $5K | 2023 |
| University Of Minnesota FoundationCovid-19 Research | Minneapolis, MN | $3K | 2023 |
Expenses: $104K
Male contraception, family planning, and agingParsemus Foundation supports contraception and family planning initiatives, focused mainly on the oversight of the development of the Vasalgel male contraceptive.The foundation continued to consult with NEXT Life Sciences, the organization that licensed the Vasalgel technology. This included monthly meetings, evaluation of progress, and coordination of media efforts. The company has made significant progress toward human clinical trials of "Plan A", the name of the NEXT Life Sciences product using Vasalgel technology.The progress on programs made possible by gifts from the foundation to a family planning organization continued to be monitored.A grant to study the influence of lithium orotate on the development of Alzheimers disease and dementia was made to the University of Saskatchewan. The study uses a mouse model of the disease.
Expenses: $75K
| 2018 | 990PF | View |
| 2017 | 990PF | View |
| 2016 | 990PF | View |
| 2015 | 990PF | View |
| Johns Hopkins University CaatCAAT support alternatives to animal testing | Baltimore, MD | $8K | 2022 |
| Research Publication GranteeJanet Wood Innovation Award | San Francisco, CA | $3K | 2022 |
| Male Contraception InitiativeGeneral Support | Durham, NC | $2K | 2022 |
| Inter Consortium For Male ContracepGeneral Support | Paris | $2K | 2022 |
| Dr Susan Love FoundationGeneral Support | West Hollywood, CA | $100 | 2022 |
| Lsu Health FoundationMMR Preventive COVID 19 Research | New Orleans, LA | $100K | 2020 |
| Amico Andrologo OnlusBPH Study | Roma | $4K | 2020 |
| MdpiCalcium chloride paper | Basel | $2K | 2020 |
© 2026 Granted AI